MiNK Therapeutics, Inc.
INKT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001840229
No open-market purchases or sales by MiNK Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.39M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in MiNK Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +21 vs. Q3 2021
- Shares held
- 1.34M
- +1.34M vs. Q3 2021
- Total value
- $5.96M
- +$5.96M vs. Q3 2021
- New holders
- 21
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INKT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $2.39M |
| Q1 2026 | 23 | $1.34M |
| Q4 2025 | 25 | $1.71M |
| Q3 2025 | 18 | $1.28M |
| Q2 2025 | 19 | $460.8K |
| Q1 2025 | 17 | $544.2K |
| Q4 2024 | 23 | $564.9K |
| Q3 2024 | 26 | $632.3K |
| Q2 2024 | 31 | $847.8K |
| Q1 2024 | 34 | $848.1K |
| Q4 2023 | 36 | $1.05M |
| Q3 2023 | 36 | $800.0K |
| Q2 2023 | 45 | $3.10M |
| Q1 2023 | 12 | $1.15M |
| Q4 2022 | 16 | $1.70M |
| Q3 2022 | 11 | $1.00M |
| Q2 2022 | 13 | $504.0K |
| Q1 2022 | 25 | $1.76M |
| Q4 2021 | 21 | $5.96M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding MiNK Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| RTW Investments, LP | 416,666 | $1.86M | 0.03% | +416,666 | New |
| Sofinnova Investments, Inc. | 345,499 | $1.54M | 0.10% | +345,499 | New |
| Artal Group S.A. | 289,588 | $1.29M | 0.04% | +289,588 | New |
| Millennium Management LLC | 68,509 | $306.0K | 0.00% | +68,509 | New |
| Morgan Stanley | 42,570 | $189.0K | 0.00% | +42,570 | New |
| Gyon Technologies Capital Management, LP | 42,448 | $189.0K | 0.03% | +42,448 | New |
| Renaissance Technologies LLC | 35,100 | $157.0K | 0.00% | +35,100 | New |
| Geode Capital Management, LLC | 23,575 | $105.0K | 0.00% | +23,575 | New |
| Invesco Ltd. | 21,066 | $94.0K | 0.00% | +21,066 | New |
| State Street Corp | 11,929 | $53.0K | 0.00% | +11,929 | New |
| Vanguard Group Inc | 10,771 | $48.0K | 0.00% | +10,771 | New |
| BlackRock Inc. | 10,399 | $46.0K | 0.00% | +10,399 | New |
| New York State Common Retirement Fund | 8,000 | $36.0K | 0.00% | +8,000 | New |
| UBS Group AG | 3,934 | $18.0K | 0.00% | +3,934 | New |
| Bank of America Corp | 1,847 | $8.00K | 0.00% | +1,847 | New |
| Tower Research Capital LLC (TRC) | 1,826 | $8.00K | 0.00% | +1,826 | New |
| American International Group, Inc. | 1,037 | $5.00K | 0.00% | +1,037 | New |
| Wells Fargo & Company | 1,207 | $5.00K | 0.00% | +1,207 | New |
| Citigroup Inc | 909 | $4.00K | 0.00% | +909 | New |
| Royal Bank of Canada | 485 | $2.00K | 0.00% | +485 | New |
| Ameritas Investment Partners, Inc. | 150 | $1.00K | 0.00% | +150 | New |